Dominika Wioletta Radomska

Dr. Dominika Wioletta Radomska

Medical University of Bialystok, Department of Synthesis and Technology of Drugs
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Dominika Wioletta RadomskaDominika Wioletta Radomska
Dominika Wioletta Radomska
RCRobert Czarnomysy
Robert Czarnomysy
DRDominik Radomski
Dominik Radomski
KBKrzysztof Bielawski
Krzysztof Bielawski
The high number of new cancer incidences and the associated mortality continue to be alarming, leading to the search for new therapies that would be more effective and less burdensome for patients. As there is evidence that Se compounds can have chemopreventive activity, studies have begun to establish whether these compounds can also affect already existing cancers. This review aims to discuss the different classes of Se-containing compounds, both organic and inorganic, natural and synthetic, and the mechanisms and molecular targets of their anticancer activity. The chemical classes discussed in this paper include inorganic (selenite, selenate) and organic compounds, such as diselenides, selenides, selenoesters, methylseleninic acid, 1,2-benzisoselenazole-3[2H]-one and selenophene-based derivatives, as well as selenoamino acids and Selol.

Verified
Journal Article
Open access
PDF file
RCRobert Czarnomysy
Robert Czarnomysy
Dominika Wioletta RadomskaDominika Wioletta Radomska
Dominika Wioletta Radomska
OSOlga Klaudia Szewczyk-Roszczenko
Olga Klaudia Szewczyk-Roszczenko
Piotr RoszczenkoPiotr Roszczenko
Piotr Roszczenko
KBKrzysztof Bielawski
Krzysztof Bielawski
There is a need for new, safer, and more effective agents to treat cancer. Cytostatics that have transition metals at their core have attracted renewed interest from scientists. Researchers are attempting to use chemotherapeutics, such as cisplatin, in combination therapy (i.e., in order to enhance their effectiveness). Moreover, studies are being carried out to modify molecules, by developing them into multinuclear structures, linking different compounds to commonly used drugs, or encapsulating them in nanoparticles to improve pharmacokinetic parameters, and increase the selectivity of these drugs. Therefore, we attempted to organize recent drug findings that contain palladium and platinum atoms in their structures.

13 May 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Dominika Wioletta RadomskaDominika Wioletta Radomska
Dominika Wioletta Radomska
RCRobert Czarnomysy
Robert Czarnomysy
DRDominik Radomski
Dominik Radomski
ABAnna Bielawska
Anna Bielawska
KBKrzysztof Bielawski
Krzysztof Bielawski
This review answers the question of why selenium is such an important trace element in the human diet. Daily dietary intake of selenium and its content in various food products is discussed in this paper, as well as the effects of its deficiency and excess in the body. Moreover, the biological activity of selenium, which it performs mainly through selenoproteins, is discussed. These specific proteins are responsible for thyroid hormone management, fertility, the aging process, and immunity, but their key role is to maintain a redox balance in cells. Furthermore, taking into account world news and the current SARS-CoV-2 virus pandemic, the impact of selenium on the course of COVID-19 is also discussed. Another worldwide problem is the number of new cancer cases and cancer-related mortality. Thus, the last part of the article discusses the impact of selenium on cancer risk based on clinical trials (including NPC and SELECT), systematic reviews, and meta-analyses. Additionally, this review discusses the possible mechanisms of selenium action that prevent cancer development.

23 September 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
AKAgnieszka Kopystecka
Agnieszka Kopystecka
IKIlona Kozioł
Ilona Kozioł
Dominika Wioletta RadomskaDominika Wioletta Radomska
Dominika Wioletta Radomska
KBKrzysztof Bielawski
Krzysztof Bielawski
ABAnna Bielawska
Anna Bielawska
Monika WujecMonika Wujec
Monika Wujec
Vaccinium uliginosum L. (commonly known as bog bilberry) and Vaccinium myrtillus L. (commonly known as bilberry) are species of the genus Vaccinium (family Ericaceae). The red–purple–blue coloration of blueberries is attributed largely to the anthocyanins found in bilberries. Anthocyanins, known for their potent biological activity as antioxidants, have a significant involvement in the prophylaxis of cancer or other diseases, including those of metabolic origin. Bilberry is the most important economically wild berry in Northern Europe, and it is also extensively used in juice and food production. A review of the latest literature was performed to assess the composition and biological activity of V. uliginosum and V. myrtillus. Clinical studies confirm the benefits of V. uliginosum and V. myrtillus supplementation as part of a healthy diet. Because of their antioxidant, anti-inflammatory, anti-cancer, and apoptosis-reducing activity, both bog bilberries and bilberries can be used interchangeably as a dietary supplement with anti-free radical actions in the prevention of cancer diseases and cataracts, or as a component of sunscreen preparations.

21 June 2020 in Molecules
Verified
Journal Article
Open access
PDF file
RCRobert Czarnomysy
Robert Czarnomysy
Dominika Wioletta RadomskaDominika Wioletta Radomska
Dominika Wioletta Radomska
AMAnna Muszyńska
Anna Muszyńska
JHJustyna Hermanowicz
Justyna Hermanowicz
IPIzabela Prokop
Izabela Prokop
KBKrzysztof Bielawski
Krzysztof Bielawski
Novel transition metal complexes (Au, Pd, Pt) with berenil and 2-(1-methyl-5-nitroimidazol-2-yl)ethanol were obtained through two-step synthesis. The cytotoxicity assay against MCF-7 and MDA-MB-231 breast cancer cells revealed that novel platinum and palladium complexes cause a reduction on the viability of MCF-7 and MDA-MB-231 breast cancer cells to a greater extent than cisplatin. The complexes showed lower cytotoxicity on normal MCF-10A human breast epithelial cells than on tumor cells. Furthermore, we observed that these complexes selectively concentrate in tumor cell mitochondria due to the characteristic for these cells increased membrane potential that may explain their increased proapoptotic activity. The activity of the synthesized compounds against topoisomerase type IIα and their increased impact on DNA defragmentation also were documented. The novel complexes also induced autophagosome changes and inhibited tumor growth in xenograft models (established using breast cancer cells).

27 July 2024 in Molecules
Verified
Journal Article
Open access
PDF file
JNJustyna Nowakowska
Justyna Nowakowska
Dominika Wioletta RadomskaDominika Wioletta Radomska
Dominika Wioletta Radomska
RCRobert Czarnomysy
Robert Czarnomysy
Krzysztof MarciniecKrzysztof Marciniec
Krzysztof Marciniec
Cancer is the second leading cause of death in the world following cardiovascular disease. Its treatment, including radiation therapy and surgical removal of the tumour, is based on pharmacotherapy, which prompts a constant search for new and more effective drugs. There are high costs associated with designing, synthesising, and marketing new substances. Drug repositioning is an attractive solution. Fluoroquinolones make up a group of synthetic antibiotics with a broad spectrum of activity in bacterial diseases. Moreover, those compounds are of particular interest to researchers as a result of reports of their antiproliferative effects on the cells of the most lethal cancers. This article presents the current progress in the development of new fluoroquinolone derivatives with potential anticancer and cytotoxic activity, as well as structure–activity relationships, along with possible directions for further development.